Definition/General

Introduction:
-Juvenile papillomatosis is a rare benign proliferative breast lesion that typically affects adolescents and young women
-It is characterized by a combination of ductal hyperplasia, papillomatosis, and cysts, leading to the term "Swiss cheese disease".
Origin: It arises from the terminal duct-lobular unit (TDLU).
Classification: It is classified as a benign proliferative breast lesion.
Epidemiology:
-It is most common in women under 30 years of age
-There is often a family history of breast cancer.

Clinical Features

Presentation: Presents as a painless, firm, well-circumscribed, palpable mass.
Symptoms: A painless breast lump is the most common symptom.
Risk Factors: A family history of breast cancer is a significant risk factor.
Screening: Mammography and ultrasound show a well-defined, heterogeneous mass.

Master Juvenile Papillomatosis Pathology with RxDx

Access 100+ pathology videos and expert guidance with the RxDx app

Gross Description

Appearance:
-A well-circumscribed, nodular mass with a variegated cut surface showing numerous small cysts.
Characteristics: The cysts are filled with clear or bloody fluid.
Size Location:
-Size is variable, but can be large.
Multifocality: Usually unifocal.

Microscopic Description

Histological Features:
-The lesion is characterized by a florid proliferation of ducts and ductules, forming papillary structures and cysts of varying sizes
-The stroma is often sclerotic
-The key features are papillomatosis, ductal hyperplasia, and cysts.
Cellular Characteristics:
-The epithelial proliferation is typically of the usual ductal hyperplasia (UDH) type, without significant atypia
-Apocrine metaplasia is common.
Architectural Patterns: The "Swiss cheese" appearance is due to the numerous cysts.
Grading Criteria:
-This is a benign lesion
-Atypia can be present in some cases.

Immunohistochemistry

Positive Markers:
-The myoepithelial cell layer is intact and can be highlighted by myoepithelial markers
-The epithelial cells are typically ER-positive.
Negative Markers: Not typically required for diagnosis.
Diagnostic Utility: IHC for myoepithelial markers can be used to confirm the benign nature of the lesion.
Molecular Subtypes: Molecular subtyping is not relevant for this benign condition.

Molecular/Genetic

Genetic Mutations: Not well characterized.
Molecular Markers: No specific molecular markers are routinely used for diagnosis.
Prognostic Significance:
-Juvenile papillomatosis is associated with an increased risk of subsequent breast cancer, both for the patient and for her family members.
Therapeutic Targets: Surgical excision is the standard treatment.

Differential Diagnosis

Similar Entities:
-Fibroadenoma
-Papillary lesions
-Low-grade DCIS.
Distinguishing Features:
-Fibroadenomas have a more prominent stromal component
-Papillary lesions are typically more discrete
-DCIS shows monotonous cells and characteristic architecture.
Diagnostic Challenges:
-The florid hyperplasia can be mistaken for a malignant process
-Careful attention to the cytological features and the overall architecture is important.
Rare Variants: There are no specific rare variants.

Sample Pathology Report

Template Format

Sample Pathology Report

Complete Report: This is an example of how the final pathology report should be structured for this condition.

Specimen Information

[specimen type], measuring [size] cm in greatest dimension

Diagnosis

[diagnosis name]

Classification

Classification: [classification system] [grade/type]

Histological Features

Shows [architectural pattern] with [nuclear features] and [mitotic activity]

Size and Extent

Size: [X] cm, extent: [local/regional/metastatic]

Margins

Margins are [involved/uninvolved] with closest margin [X] mm

Lymphovascular Invasion

Lymphovascular invasion: [present/absent]

Lymph Node Status

Lymph nodes: [X] positive out of [X] examined

Special Studies

IHC: [marker]: [result]

Molecular: [test]: [result]

[other study]: [result]

Final Diagnosis

Final diagnosis: [complete diagnosis]